Illumina, Inc. (ILMN)
USD 134.03
(-6.35%)
USD 134.03
(-6.35%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.74 Billion USD | -7.47% |
| 2022 | 2.97 Billion USD | -5.77% |
| 2021 | 3.15 Billion USD | 43.17% |
| 2020 | 2.2 Billion USD | -10.7% |
| 2019 | 2.46 Billion USD | 7.26% |
| 2018 | 2.3 Billion USD | 25.96% |
| 2017 | 1.82 Billion USD | 9.57% |
| 2016 | 1.66 Billion USD | 7.56% |
| 2015 | 1.54 Billion USD | 19.39% |
| 2014 | 1.29 Billion USD | 42.31% |
| 2013 | 911.88 Million USD | 17.89% |
| 2012 | 773.52 Million USD | 9.09% |
| 2011 | 709.09 Million USD | 17.88% |
| 2010 | 601.54 Million USD | 30.61% |
| 2009 | 460.55 Million USD | 25.29% |
| 2008 | 367.6 Million USD | 56.85% |
| 2007 | 234.36 Million USD | 87.13% |
| 2006 | 125.24 Million USD | 148.89% |
| 2005 | 50.32 Million USD | 34.82% |
| 2004 | 37.32 Million USD | 107.38% |
| 2003 | 17.99 Million USD | 176.72% |
| 2002 | 6.5 Million USD | 237.17% |
| 2001 | 1.92 Million USD | 12.99% |
| 2000 | 1.7 Million USD | 199.32% |
| 1999 | 570.39 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 745 Million USD | 3.33% |
| 2024 Q1 | 667 Million USD | -1.19% |
| 2024 Q2 | 721 Million USD | 8.1% |
| 2023 Q2 | 732 Million USD | 11.76% |
| 2023 Q1 | 655 Million USD | -2.53% |
| 2023 FY | 2.75 Billion USD | -7.47% |
| 2023 Q4 | 675 Million USD | -1.32% |
| 2023 Q3 | 684 Million USD | -6.56% |
| 2022 FY | 2.97 Billion USD | -5.77% |
| 2022 Q4 | 672 Million USD | -6.28% |
| 2022 Q3 | 717 Million USD | -6.52% |
| 2022 Q2 | 767 Million USD | -5.89% |
| 2022 Q1 | 815 Million USD | -0.24% |
| 2021 Q1 | 764 Million USD | 21.27% |
| 2021 Q2 | 802 Million USD | 4.97% |
| 2021 Q4 | 817 Million USD | 6.1% |
| 2021 Q3 | 770 Million USD | -3.99% |
| 2021 FY | 3.15 Billion USD | 43.17% |
| 2020 Q3 | 526 Million USD | 22.9% |
| 2020 Q4 | 630 Million USD | 19.77% |
| 2020 FY | 2.2 Billion USD | -10.7% |
| 2020 Q1 | 619 Million USD | -6.5% |
| 2020 Q2 | 428 Million USD | -30.86% |
| 2019 Q4 | 662 Million USD | 2.16% |
| 2019 FY | 2.46 Billion USD | 7.26% |
| 2019 Q1 | 584 Million USD | -1.02% |
| 2019 Q2 | 573 Million USD | -1.88% |
| 2019 Q3 | 648 Million USD | 13.09% |
| 2018 FY | 2.3 Billion USD | 25.96% |
| 2018 Q1 | 538 Million USD | -0.74% |
| 2018 Q2 | 575 Million USD | 6.88% |
| 2018 Q3 | 597 Million USD | 3.83% |
| 2018 Q4 | 590 Million USD | -1.17% |
| 2017 Q1 | 368 Million USD | -12.26% |
| 2017 FY | 1.82 Billion USD | 9.57% |
| 2017 Q4 | 542 Million USD | 12.45% |
| 2017 Q3 | 482 Million USD | 11.06% |
| 2017 Q2 | 434 Million USD | 17.93% |
| 2016 FY | 1.66 Billion USD | 7.56% |
| 2016 Q4 | 419.43 Million USD | -1.57% |
| 2016 Q1 | 397.05 Million USD | -3.24% |
| 2016 Q3 | 426.15 Million USD | 0.55% |
| 2016 Q2 | 423.8 Million USD | 6.74% |
| 2015 Q1 | 375.02 Million USD | -2.57% |
| 2015 Q4 | 410.35 Million USD | 5.89% |
| 2015 Q2 | 376.36 Million USD | 0.36% |
| 2015 Q3 | 387.53 Million USD | 2.97% |
| 2015 FY | 1.54 Billion USD | 19.39% |
| 2014 Q4 | 384.93 Million USD | 15.27% |
| 2014 Q3 | 333.94 Million USD | 11.11% |
| 2014 Q2 | 300.54 Million USD | 7.99% |
| 2014 Q1 | 278.29 Million USD | 7.35% |
| 2014 FY | 1.29 Billion USD | 42.31% |
| 2013 FY | 911.88 Million USD | 17.89% |
| 2013 Q4 | 259.24 Million USD | 23.49% |
| 2013 Q3 | 209.94 Million USD | -6.03% |
| 2013 Q2 | 223.4 Million USD | 1.88% |
| 2013 Q1 | 219.29 Million USD | 7.68% |
| 2012 Q4 | 203.64 Million USD | 3.97% |
| 2012 Q1 | 181.01 Million USD | 6.11% |
| 2012 Q3 | 195.87 Million USD | 1.49% |
| 2012 FY | 773.52 Million USD | 9.09% |
| 2012 Q2 | 192.99 Million USD | 6.62% |
| 2011 Q2 | 193.35 Million USD | 2.83% |
| 2011 Q1 | 188.04 Million USD | 8.11% |
| 2011 FY | 709.09 Million USD | 17.88% |
| 2011 Q4 | 170.58 Million USD | 8.57% |
| 2011 Q3 | 157.11 Million USD | -18.74% |
| 2010 FY | 601.54 Million USD | 30.61% |
| 2010 Q2 | 146.09 Million USD | 10.53% |
| 2010 Q3 | 157.14 Million USD | 7.57% |
| 2010 Q1 | 132.17 Million USD | 3.92% |
| 2010 Q4 | 173.93 Million USD | 10.68% |
| 2009 FY | 460.55 Million USD | 25.29% |
| 2009 Q1 | 111.73 Million USD | 5.14% |
| 2009 Q2 | 112.82 Million USD | 0.98% |
| 2009 Q4 | 127.19 Million USD | 16.91% |
| 2009 Q3 | 108.79 Million USD | -3.57% |
| 2008 FY | 367.6 Million USD | 56.85% |
| 2008 Q4 | 106.27 Million USD | 10.9% |
| 2008 Q3 | 95.83 Million USD | 6.81% |
| 2008 Q2 | 89.71 Million USD | 18.39% |
| 2008 Q1 | 75.78 Million USD | 4.51% |
| 2007 Q2 | 54.39 Million USD | 15.66% |
| 2007 Q1 | 47.03 Million USD | 16.65% |
| 2007 FY | 234.36 Million USD | 87.13% |
| 2007 Q4 | 72.5 Million USD | 19.98% |
| 2007 Q3 | 60.43 Million USD | 11.1% |
| 2006 Q4 | 40.31 Million USD | 8.62% |
| 2006 FY | 125.24 Million USD | 148.89% |
| 2006 Q1 | 19.8 Million USD | 25.66% |
| 2006 Q2 | 28 Million USD | 41.35% |
| 2006 Q3 | 37.11 Million USD | 32.55% |
| 2005 FY | 50.32 Million USD | 34.82% |
| 2005 Q2 | 11.09 Million USD | 5.13% |
| 2005 Q3 | 12.91 Million USD | 16.47% |
| 2005 Q4 | 15.76 Million USD | 22.04% |
| 2005 Q1 | 10.54 Million USD | -3.3% |
| 2004 Q2 | 8.41 Million USD | 5.22% |
| 2004 Q4 | 10.9 Million USD | 9.14% |
| 2004 Q3 | 9.99 Million USD | 18.72% |
| 2004 Q1 | 8 Million USD | 9.29% |
| 2004 FY | 37.32 Million USD | 107.38% |
| 2003 Q2 | 2.74 Million USD | 15.93% |
| 2003 Q3 | 5.56 Million USD | 102.99% |
| 2003 Q4 | 7.32 Million USD | 31.48% |
| 2003 Q1 | 2.36 Million USD | 5.16% |
| 2003 FY | 17.99 Million USD | 176.72% |
| 2002 Q2 | 1.3 Million USD | 40.22% |
| 2002 Q4 | 2.25 Million USD | 11.39% |
| 2002 Q3 | 2.02 Million USD | 54.91% |
| 2002 Q1 | 930 Thousand USD | 90.5% |
| 2002 FY | 6.5 Million USD | 237.17% |
| 2001 FY | 1.92 Million USD | 12.99% |
| 2001 Q3 | 489.77 Thousand USD | 4.24% |
| 2001 Q2 | 469.84 Thousand USD | -14.6% |
| 2001 Q1 | 550.14 Thousand USD | -14.86% |
| 2001 Q4 | 488.17 Thousand USD | -0.33% |
| 2000 Q3 | 836.4 Thousand USD | 471.36% |
| 2000 Q4 | 646.19 Thousand USD | -22.74% |
| 2000 Q1 | 78.28 Thousand USD | 0.0% |
| 2000 FY | 1.7 Million USD | 199.32% |
| 2000 Q2 | 146.39 Thousand USD | 87.0% |
| 1999 FY | 570.39 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Bionano Genomics, Inc. | 9.56 Million USD | -28584.926% |
| Prenetics Global Limited | 8.82 Million USD | -30976.275% |
| Star Equity Holdings, Inc. | 11.92 Million USD | -22908.553% |
| CareDx, Inc | 178.32 Million USD | -1438.763% |
| Exact Sciences Corporation | 1.84 Billion USD | -48.685% |
| Exagen Inc. | 29.45 Million USD | -9215.589% |
| Inotiv, Inc. | 165.44 Million USD | -1558.577% |
| Guardant Health, Inc. | 336.89 Million USD | -714.495% |
| Biodesix, Inc. | 36.07 Million USD | -7505.954% |
| BioNexus Gene Lab Corp. | 1.32 Million USD | -206293.691% |
| Precipio, Inc. | 6.01 Million USD | -45496.544% |
| iSpecimen Inc. | 5.1 Million USD | -53620.539% |
| Natera, Inc. | 492.74 Million USD | -456.886% |
| Aspira Women's Health Inc. | 5.26 Million USD | -52047.472% |
| Standard BioTools Inc. | 50.45 Million USD | -5339.049% |
| 23andMe Holding Co. | 99.37 Million USD | -2661.202% |
| Castle Biosciences, Inc. | 174.8 Million USD | -1469.74% |
| Personalis, Inc. | 18.2 Million USD | -14970.299% |
| Aclaris Therapeutics, Inc. | 13.16 Million USD | -20738.396% |
| Applied DNA Sciences, Inc. | 5.53 Million USD | -49489.477% |
| OpGen, Inc. | -90.69 Thousand USD | 3025658.471% |
| T2 Biosystems, Inc. | -8.17 Million USD | 33686.291% |
| Myriad Genetics, Inc. | 476.4 Million USD | -475.987% |
| ICON Public Limited Company | 1.81 Billion USD | -51.245% |
| NeoGenomics, Inc. | 244.6 Million USD | -1021.813% |
| Star Equity Holdings, Inc. | 11.92 Million USD | -22908.553% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | -25.299% |
| RadNet, Inc. | 93 Million USD | -2850.538% |
| MDxHealth SA | 43.92 Million USD | -6146.443% |
| Psychemedics Corporation | 8.41 Million USD | -32516.189% |
| Check-Cap Ltd. | -212 Thousand USD | 1294439.623% |
| Twist Bioscience Corporation | 133.34 Million USD | -1957.758% |
| DarioHealth Corp. | 5.98 Million USD | -45755.615% |
| Fulgent Genetics, Inc. | 104.45 Million USD | -2526.943% |
| Sera Prognostics, Inc. | 96 Thousand USD | -2858233.333% |
| ENDRA Life Sciences Inc. | -275.45 Thousand USD | 996284.439% |
| OPKO Health, Inc. | 318.12 Million USD | -762.549% |
| Medpace Holdings, Inc. | 524.5 Million USD | -423.16% |
| Neogen Corporation | 463.9 Million USD | -491.507% |
| Intelligent Bio Solutions Inc. | 1.42 Million USD | -192376.849% |
| Prenetics Global Limited | 8.82 Million USD | -30976.275% |
| Mainz Biomed B.V. | 509.65 Thousand USD | -538299.204% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -346533.149% |
| Trinity Biotech plc | 19.45 Million USD | -14007.969% |
| Neuronetics, Inc. | 51.7 Million USD | -5207.03% |
| Sotera Health Company | 577.15 Million USD | -375.433% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -346533.149% |